(Alliance News) - Chemring Group PLC on Tuesday hailed a record order intake which underpinned confidence in hitting full-year financial guidance.

Chemring is a Hampshire, England-based provider of technology products and services to aerospace, defence and security markets.

Pretax profit fell 31% to GBP15.2 million in the six months that ended April 30 from GBP22.1 million a year prior.

This came despite a 8.3% increase in revenue to GBP223.4 million from GBP206.3 million a year prior. This was driven by a strong performance at Roke, up 19%, and growth in its specialist energetic materials businesses offset by a weaker period for Countermeasures.

But underlying operating profit margin dipped to 11.2% from 12.7% primarily reflecting the impact of operational challenges at the Tennessee Countermeasures business in the period.

Chemring said the first half performance was in line with the board's expectations.

Looking ahead, Chemring said it has an ambition to increase annual revenue to around GBP1 billion by 2030.

Chemring highlighted a record first-half order intake of GBP344.5 million and an order book of GBP1.04 billion, up 1.9% and 39%, respectively, from GBP338.2 million and GBP749.5 million a year prior.

Chief Executive Michael Ord commented: "The momentum seen in 2023 has continued with another period of record order intake and an order book of over GBP1 billion, the highest in Chemring's history. This strong order intake across both sectors has further increased our order cover for the second half of 2024 to 93% and the board's expectations for the full year are unchanged."

Reflecting this, the company increased the interim dividend by 13% to 2.60 pence per share from 2.3p a year prior.

Shares in Chemring were down 0.6% to 392.00 pence in London on Tuesday morning.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.